Dyax Completes Rolling BLA For HAE Candidate DX-88

Company seeks priority review, which if granted could set an FDA action date in March.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet